JSM 2015 Preliminary Program

Online Program Home
My Program

Legend: Washington State Convention Center = CC, Sheraton Seattle = S, Grand Hyatt = GH and The Conference Center = TCC
* = applied session       ! = JSM meeting theme

Activity Details
290 * ! Tue, 8/11/2015, 8:30 AM - 10:20 AM CC-4C4
Estimands and Their Role in Clinical Trials: Defining Suitable Primary Scientific Questions of Interest — Invited Papers
Biopharmaceutical Section , Biometrics Section , Section on Medical Devices and Diagnostics
Organizer(s): Frank Bretz, Novartis
Chair(s): Mouna Akacha, Novartis
8:35 AM Evaluating Effectiveness of a New Treatment Indication: A Succession of Clinical Trials with Varying Estimands — Scott Emerson, University of Washington
9:00 AM Choosing Estimands in Clinical Trials with Missing Data — Craig H. Mallinckrodt, Eli Lilly and Company
9:25 AM What to Estimate in Symptom Trials — Thomas Permutt, FDA
9:50 AM Discussant: Roderick Little, University of Michigan
10:15 AM Floor Discussion




For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home